 | • レポートコード：20QY06-07111 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、粗ヘパリンのグローバル市場について種類別（豚腸粘膜ヘパリン、牛ヘパリン他）、用途別（UFH、LMWH）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・粗ヘパリン市場の概要 ・世界の主要地域別粗ヘパリン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の粗ヘパリン市場規模2015-2026：種類別（豚腸粘膜ヘパリン、牛ヘパリン他） ・世界の粗ヘパリン市場規模2015-2026：用途別（UFH、LMWH） ・粗ヘパリンの北米市場規模2015-2020 ・粗ヘパリンのヨーロッパ市場規模2015-2020 ・粗ヘパリンの中国市場規模2015-2020 ・粗ヘパリンの日本市場規模2015-2020 ・粗ヘパリンの東南アジア市場規模2015-2020 ・粗ヘパリンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Shenzhen Hepalink Pharmaceutical Group Co., Ltd、Bioiberica、Sanofi、Fengrun Biological Technology Co., Ltd.、Nanjing King-friend Biochemical Pharmaceutical、Hebei Changshan Biochemical Pharmaceutical、Changzhou Qianhong Biopharma Co.,Ltd、Aspen Oss、Hepac (Darling Ingredients)、Yantai Dongcheng Biochemicals Co., Ltd、Huaian MDC Pharmaceutical Co., Ltd） ・粗ヘパリンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・粗ヘパリンの市場動向・機会・課題 ・調査の結論 |
Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
The top five manufacturers which are Shenzhen Hepalink, Pharma Action (Tönnies Group), Fengrun Biological, Nanjing King-friend, Aspen Oss held 37% of the market, in terms of crude heparin revenue in 2018.
Market Analysis and Insights: Global Crude Heparin Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Crude Heparin market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Crude Heparin industry.
Based on our recent survey, we have several different scenarios about the Crude Heparin YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2438 million in 2019. The market size of Crude Heparin will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Crude Heparin Scope and Market Size
The global Crude Heparin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Crude Heparin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Crude Heparin market is segmented into
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
Pig intestine mucosa heparin is almost the only used and efficient types and took 99.6% market share in 2018.
Segment by Application, the Crude Heparin market is segmented into
UFH
LMWH
LMWH is the largest consumer group, with market share of 89% in 2018.
The Crude Heparin market is analysed and market size information is provided by regions (countries). Segment by Application, the Crude Heparin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Crude Heparin Market Share Analysis
Crude Heparin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Crude Heparin business, the date to enter into the Crude Heparin market, Crude Heparin product introduction, recent developments, etc.
The major vendors covered:
Shenzhen Hepalink Pharmaceutical Group Co., Ltd
Bioiberica
Sanofi
Fengrun Biological Technology Co., Ltd.
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Changzhou Qianhong Biopharma Co.,Ltd
Aspen Oss
Hepac (Darling Ingredients)
Yantai Dongcheng Biochemicals Co., Ltd
Huaian MDC Pharmaceutical Co., Ltd
1 Crude Heparin Market Overview
1.1 Crude Heparin Product Scope
1.2 Crude Heparin Segment by Type
1.2.1 Global Crude Heparin Sales by Type (2020-2026)
1.2.2 Pig Intestine Mucosa Heparin
1.2.3 Bovine Heparin and Others
1.3 Crude Heparin Segment by Application
1.3.1 Global Crude Heparin Sales Comparison by Application (2020-2026)
1.3.2 UFH
1.3.3 LMWH
1.4 Crude Heparin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Crude Heparin Sales Growth Rate (2015-2026)
1.4.2 Global Crude Heparin Revenue and Growth Rate (2015-2026)
1.4.3 Global Crude Heparin Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Crude Heparin Industry Impact
1.5.1 How the Covid-19 is Affecting the Crude Heparin Industry
1.5.1.1 Crude Heparin Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Crude Heparin Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Crude Heparin Players to Combat Covid-19 Impact
2 Crude Heparin Estimate and Forecast by Region
2.1 Global Crude Heparin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Crude Heparin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Crude Heparin Sales Market Share by Region (2015-2020)
2.2.2 Global Crude Heparin Revenue Market Share by Region (2015-2020)
2.3 Global Crude Heparin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Crude Heparin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Crude Heparin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Crude Heparin Estimates and Projections (2015-2026)
2.4.2 Europe Crude Heparin Estimates and Projections (2015-2026)
2.4.3 China Crude Heparin Estimates and Projections (2015-2026)
2.4.4 Japan Crude Heparin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Crude Heparin Estimates and Projections (2015-2026)
2.4.6 India Crude Heparin Estimates and Projections (2015-2026)
3 Global Crude Heparin Competition Landscape by Players
3.1 Global Top Crude Heparin Players by Sales (2015-2020)
3.2 Global Top Crude Heparin Players by Revenue (2015-2020)
3.3 Global Crude Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crude Heparin as of 2019)
3.4 Global Crude Heparin Average Price by Company (2015-2020)
3.5 Manufacturers Crude Heparin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Crude Heparin Players (Opinion Leaders)
4 Global Crude Heparin Market Size by Type
4.1 Global Crude Heparin Historic Market Review by Type (2015-2020)
4.1.1 Global Crude Heparin Sales Market Share by Type (2015-2020)
4.1.2 Global Crude Heparin Revenue Market Share by Type (2015-2020)
4.1.3 Global Crude Heparin Price by Type (2014-2020)
4.2 Global Crude Heparin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Crude Heparin Sales Forecast by Type (2021-2026)
4.2.2 Global Crude Heparin Revenue Forecast by Type (2021-2026)
4.2.3 Global Crude Heparin Price Forecast by Type (2021-2026)
5 Global Crude Heparin Market Size by Application
5.1 Global Crude Heparin Historic Market Review by Application (2015-2020)
5.1.1 Global Crude Heparin Sales Market Share by Application (2015-2020)
5.1.2 Global Crude Heparin Revenue Market Share by Application (2015-2020)
5.1.3 Global Crude Heparin Price by Application (2015-2020)
5.2 Global Crude Heparin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Crude Heparin Sales Forecast by Application (2021-2026)
5.2.2 Global Crude Heparin Revenue Forecast by Application (2021-2026)
5.2.3 Global Crude Heparin Price Forecast by Application (2021-2026)
3 North America Crude Heparin Market Facts & Figures
3.2 North America Crude Heparin Sales Market Share by Company (2015-2020)
3.3 North America Crude Heparin Sales Market Share by Type (2015-2020)
3.4 North America Crude Heparin Sales Market Share by Application (2015-2020)
4 Europe Crude Heparin Market Facts & Figures
4.2 Europe Crude Heparin Sales Market Share by Company (2015-2020)
4.3 Europe Crude Heparin Sales Market Share by Type (2015-2020)
4.4 Europe Crude Heparin Sales Market Share by Application (2015-2020)
5 China Crude Heparin Market Facts & Figures
5.2 China Crude Heparin Sales Market Share by Company (2015-2020)
5.3 China Crude Heparin Sales Market Share by Type (2015-2020)
5.4 China Crude Heparin Sales Market Share by Application (2015-2020)
6 Japan Crude Heparin Market Facts & Figures
6.2 Japan Crude Heparin Sales Market Share by Company (2015-2020)
6.3 Japan Crude Heparin Sales Market Share by Type (2015-2020)
6.4 Japan Crude Heparin Sales Market Share by Application (2015-2020)
7 Southeast Asia Crude Heparin Market Facts & Figures
7.2 Southeast Asia Crude Heparin Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Crude Heparin Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Crude Heparin Sales Market Share by Application (2015-2020)
8 India Crude Heparin Market Facts & Figures
8.2 India Crude Heparin Sales Market Share by Company (2015-2020)
8.3 India Crude Heparin Sales Market Share by Type (2015-2020)
8.4 India Crude Heparin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Crude Heparin Business
12.1 Shenzhen Hepalink Pharmaceutical Group Co., Ltd
12.1.1 Shenzhen Hepalink Pharmaceutical Group Co., Ltd Crude Heparin Corporation Information
12.1.2 Shenzhen Hepalink Pharmaceutical Group Co., Ltd Crude Heparin Business Overview and Total Revenue
12.1.3 Shenzhen Hepalink Pharmaceutical Group Co., Ltd Crude Heparin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Shenzhen Hepalink Pharmaceutical Group Co., Ltd Crude Heparin Products Offered
12.1.5 Shenzhen Hepalink Pharmaceutical Group Co., Ltd Recent Development
12.2 Bioiberica
12.2.1 Bioiberica Crude Heparin Corporation Information
12.2.2 Bioiberica Crude Heparin Business Overview and Total Revenue
12.2.3 Bioiberica Crude Heparin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bioiberica Crude Heparin Products Offered
12.2.5 Bioiberica Recent Development
12.3 Sanofi
12.3.1 Sanofi Crude Heparin Corporation Information
12.3.2 Sanofi Crude Heparin Business Overview and Total Revenue
12.3.3 Sanofi Crude Heparin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Crude Heparin Products Offered
12.3.5 Sanofi Recent Development
12.4 Fengrun Biological Technology Co., Ltd.
12.4.1 Fengrun Biological Technology Co., Ltd. Crude Heparin Corporation Information
12.4.2 Fengrun Biological Technology Co., Ltd. Crude Heparin Business Overview and Total Revenue
12.4.3 Fengrun Biological Technology Co., Ltd. Crude Heparin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Fengrun Biological Technology Co., Ltd. Crude Heparin Products Offered
12.4.5 Fengrun Biological Technology Co., Ltd. Recent Development
12.5 Nanjing King-friend Biochemical Pharmaceutical
12.5.1 Nanjing King-friend Biochemical Pharmaceutical Crude Heparin Corporation Information
12.5.2 Nanjing King-friend Biochemical Pharmaceutical Crude Heparin Business Overview and Total Revenue
12.5.3 Nanjing King-friend Biochemical Pharmaceutical Crude Heparin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Nanjing King-friend Biochemical Pharmaceutical Crude Heparin Products Offered
12.5.5 Nanjing King-friend Biochemical Pharmaceutical Recent Development
12.6 Hebei Changshan Biochemical Pharmaceutical
12.6.1 Hebei Changshan Biochemical Pharmaceutical Crude Heparin Corporation Information
12.6.2 Hebei Changshan Biochemical Pharmaceutical Crude Heparin Business Overview and Total Revenue
12.6.3 Hebei Changshan Biochemical Pharmaceutical Crude Heparin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Hebei Changshan Biochemical Pharmaceutical Crude Heparin Products Offered
12.6.5 Hebei Changshan Biochemical Pharmaceutical Recent Development
12.7 Changzhou Qianhong Biopharma Co.,Ltd
12.7.1 Changzhou Qianhong Biopharma Co.,Ltd Crude Heparin Corporation Information
12.7.2 Changzhou Qianhong Biopharma Co.,Ltd Crude Heparin Business Overview and Total Revenue
12.7.3 Changzhou Qianhong Biopharma Co.,Ltd Crude Heparin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Changzhou Qianhong Biopharma Co.,Ltd Crude Heparin Products Offered
12.7.5 Changzhou Qianhong Biopharma Co.,Ltd Recent Development
12.8 Aspen Oss
12.8.1 Aspen Oss Crude Heparin Corporation Information
12.8.2 Aspen Oss Crude Heparin Business Overview and Total Revenue
12.8.3 Aspen Oss Crude Heparin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Aspen Oss Crude Heparin Products Offered
12.8.5 Aspen Oss Recent Development
12.9 Hepac (Darling Ingredients)
12.9.1 Hepac (Darling Ingredients) Crude Heparin Corporation Information
12.9.2 Hepac (Darling Ingredients) Crude Heparin Business Overview and Total Revenue
12.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Hepac (Darling Ingredients) Crude Heparin Products Offered
12.9.5 Hepac (Darling Ingredients) Recent Development
12.10 Yantai Dongcheng Biochemicals Co., Ltd
12.10.1 Yantai Dongcheng Biochemicals Co., Ltd Crude Heparin Corporation Information
12.10.2 Yantai Dongcheng Biochemicals Co., Ltd Crude Heparin Business Overview and Total Revenue
12.10.3 Yantai Dongcheng Biochemicals Co., Ltd Crude Heparin Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Yantai Dongcheng Biochemicals Co., Ltd Crude Heparin Products Offered
12.10.5 Yantai Dongcheng Biochemicals Co., Ltd Recent Development
12.11 Huaian MDC Pharmaceutical Co., Ltd
12.11.1 Huaian MDC Pharmaceutical Co., Ltd Crude Heparin Corporation Information
12.11.2 Huaian MDC Pharmaceutical Co., Ltd Crude Heparin Business Overview and Total Revenue
12.11.3 Huaian MDC Pharmaceutical Co., Ltd Crude Heparin Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Huaian MDC Pharmaceutical Co., Ltd Crude Heparin Products Offered
12.11.5 Huaian MDC Pharmaceutical Co., Ltd Recent Development
13 Crude Heparin Manufacturing Cost Analysis
13.1 Crude Heparin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Crude Heparin
13.4 Crude Heparin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Crude Heparin Distributors List
14.3 Crude Heparin Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Crude Heparin Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Crude Heparin Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Crude Heparin Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Crude Heparin Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Crude Heparin Players to Combat Covid-19 Impact
Table 8. Global Market Crude Heparin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Crude Heparin Sales (MT) by Region (2015-2020)
Table 10. Global Crude Heparin Sales Market Share by Region (2015-2020)
Table 11. Global Crude Heparin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Crude Heparin Revenue Share by Region (2015-2020)
Table 13. Global Crude Heparin Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Crude Heparin Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Crude Heparin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Crude Heparin Revenue Share Forecast by Region (2021-2026)
Table 17. Global Crude Heparin (MT) of Key Companies (2015-2020)
Table 18. Global Crude Heparin Sales Share by Company (2015-2020)
Table 19. Global Crude Heparin Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Crude Heparin Revenue Share by Company (2015-2020)
Table 21. Global Crude Heparin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crude Heparin as of 2019)
Table 22. Global Crude Heparin Average Price (K USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Crude Heparin Manufacturing Sites and Area Served
Table 24. Manufacturers Crude Heparin Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Crude Heparin Players
Table 27. Global Crude Heparin Sales (MT) by Type (2015-2020)
Table 28. Global Crude Heparin Sales Share by Type (2015-2020)
Table 29. Global Crude Heparin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Crude Heparin Price (MT) by Type (2015-2020)
Table 31. Global Crude Heparin Sales Share by Type (2021-2026)
Table 32. Global Crude Heparin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Crude Heparin Revenue Share by Type (2021-2026)
Table 34. Global Crude Heparin Price (MT) by Type (2021-2026)
Table 35. Global Crude Heparin Sales (MT) by Application (2015-2020)
Table 36. Global Crude Heparin Sales Share by Application (2015-2020)
Table 37. Global Crude Heparin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Crude Heparin Price (MT) by Application (2015-2020)
Table 39. Global Crude Heparin Sales (MT) by Application (2021-2026)
Table 40. Global Crude Heparin Sales Share by Application (2021-2026)
Table 41. Global Crude Heparin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Crude Heparin Revenue Share by Application (2021-2026)
Table 43. Global Crude Heparin Price (MT) by Application (2021-2026)
Table 44. United States Crude Heparin Sales (MT) by Company (2015-2020)
Table 45. United States Crude Heparin Sales Market Share by Company (2015-2020)
Table 46. United States Crude Heparin Sales (MT) by Type (2015-2020)
Table 47. United States Crude Heparin Sales Market Share by Type (2015-2020)
Table 48. United States Crude Heparin Sales (MT) by Application (2015-2020)
Table 49. United States Crude Heparin Sales Market Share by Application (2015-2020)
Table 50. Europe Crude Heparin Sales (MT) by Company (2015-2020)
Table 51. Europe Crude Heparin Sales Market Share by Company (2015-2020)
Table 52. Europe Crude Heparin Sales (MT) by Type (2015-2020)
Table 53. Europe Crude Heparin Sales Market Share by Type (2015-2020)
Table 54. Europe Crude Heparin Sales (MT) by Application (2015-2020)
Table 55. Europe Crude Heparin Sales Market Share by Type (2015-2020)
Table 56. China Crude Heparin Sales (MT) by Company (2015-2020)
Table 57. China Crude Heparin Sales Market Share by Company (2015-2020)
Table 58. China Crude Heparin Sales (MT) by Type (2015-2020)
Table 59. China Crude Heparin Sales Market Share by Type (2015-2020)
Table 60. China Crude Heparin Sales (MT) by Application (2015-2020)
Table 61. China Crude Heparin Sales Market Share by Application (2015-2020)
Table 62. Japan Crude Heparin Sales (MT) by Company (2015-2020)
Table 63. Japan Crude Heparin Sales Market Share by Company (2015-2020)
Table 64. Japan Crude Heparin Sales (MT) by Type (2015-2020)
Table 65. Japan Crude Heparin Sales Market Share by Type (2015-2020)
Table 66. Japan Crude Heparin Sales (MT) by Application (2015-2020)
Table 67. Japan Crude Heparin Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Crude Heparin Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Crude Heparin Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Crude Heparin Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Crude Heparin Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Crude Heparin Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Crude Heparin Sales Market Share by Application (2015-2020)
Table 74. India Crude Heparin Sales (MT) by Company (2015-2020)
Table 75. India Crude Heparin Sales Market Share by Company (2015-2020)
Table 76. India Crude Heparin Sales (MT) by Type (2015-2020)
Table 77. India Crude Heparin Sales Market Share by Type (2015-2020)
Table 78. India Crude Heparin Sales (MT) by Application (2015-2020)
Table 79. India Crude Heparin Sales Market Share by Application (2015-2020)
Table 80. Shenzhen Hepalink Pharmaceutical Group Co., Ltd Corporation Information
Table 81. Shenzhen Hepalink Pharmaceutical Group Co., Ltd Description and Business Overview
Table 82. Shenzhen Hepalink Pharmaceutical Group Co., Ltd Crude Heparin Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 83. Shenzhen Hepalink Pharmaceutical Group Co., Ltd Crude Heparin Product
Table 84. Shenzhen Hepalink Pharmaceutical Group Co., Ltd Recent Development
Table 85. Bioiberica Corporation Information
Table 86. Bioiberica Description and Business Overview
Table 87. Bioiberica Crude Heparin Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 88. Bioiberica Crude Heparin Product
Table 89. Bioiberica Recent Development
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Crude Heparin Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 93. Sanofi Crude Heparin Product
Table 94. Sanofi Recent Development
Table 95. Fengrun Biological Technology Co., Ltd. Corporation Information
Table 96. Fengrun Biological Technology Co., Ltd. Description and Business Overview
Table 97. Fengrun Biological Technology Co., Ltd. Crude Heparin Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 98. Fengrun Biological Technology Co., Ltd. Crude Heparin Product
Table 99. Fengrun Biological Technology Co., Ltd. Recent Development
Table 100. Nanjing King-friend Biochemical Pharmaceutical Corporation Information
Table 101. Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
Table 102. Nanjing King-friend Biochemical Pharmaceutical Crude Heparin Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 103. Nanjing King-friend Biochemical Pharmaceutical Crude Heparin Product
Table 104. Nanjing King-friend Biochemical Pharmaceutical Recent Development
Table 105. Hebei Changshan Biochemical Pharmaceutical Corporation Information
Table 106. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
Table 107. Hebei Changshan Biochemical Pharmaceutical Crude Heparin Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 108. Hebei Changshan Biochemical Pharmaceutical Crude Heparin Product
Table 109. Hebei Changshan Biochemical Pharmaceutical Recent Development
Table 110. Changzhou Qianhong Biopharma Co.,Ltd Corporation Information
Table 111. Changzhou Qianhong Biopharma Co.,Ltd Description and Business Overview
Table 112. Changzhou Qianhong Biopharma Co.,Ltd Crude Heparin Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 113. Changzhou Qianhong Biopharma Co.,Ltd Crude Heparin Product
Table 114. Changzhou Qianhong Biopharma Co.,Ltd Recent Development
Table 115. Aspen Oss Corporation Information
Table 116. Aspen Oss Crude Heparin Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 117. Aspen Oss Description and Business Overview
Table 118. Aspen Oss Crude Heparin Product
Table 119. Aspen Oss Recent Development
Table 120. Hepac (Darling Ingredients) Corporation Information
Table 121. Hepac (Darling Ingredients) Crude Heparin Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 122. Hepac (Darling Ingredients) Description and Business Overview
Table 123. Hepac (Darling Ingredients) Crude Heparin Product
Table 124. Hepac (Darling Ingredients) Recent Development
Table 125. Yantai Dongcheng Biochemicals Co., Ltd Corporation Information
Table 126. Yantai Dongcheng Biochemicals Co., Ltd Description and Business Overview
Table 127. Yantai Dongcheng Biochemicals Co., Ltd Crude Heparin Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table 128. Yantai Dongcheng Biochemicals Co., Ltd Crude Heparin Product
Table 129. Yantai Dongcheng Biochemicals Co., Ltd Recent Development
Table . Huaian MDC Pharmaceutical Co., Ltd Corporation Information
Table . Huaian MDC Pharmaceutical Co., Ltd Description and Business Overview
Table . Huaian MDC Pharmaceutical Co., Ltd Crude Heparin Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2015-2020)
Table . Huaian MDC Pharmaceutical Co., Ltd Crude Heparin Product
Table . Huaian MDC Pharmaceutical Co., Ltd Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Crude Heparin Distributors List
Table 138. Crude Heparin Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Crude Heparin Product Picture
Figure 2. Global Crude Heparin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Crude Heparin Market Share by Application in 2020 & 2026
Figure 6. UFH Examples
Figure 7. LMWH Examples
Figure 8. Global Crude Heparin Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Crude Heparin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Crude Heparin Price Trends Growth Rate (2015-2026) (K USD/MT)
Figure 11. Global Crude Heparin Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Crude Heparin Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Crude Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Crude Heparin Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Crude Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Crude Heparin Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Crude Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Crude Heparin Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Crude Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Crude Heparin Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Crude Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Crude Heparin Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Crude Heparin Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Crude Heparin Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Crude Heparin Players Market Share by Revenue in Crude Heparin 2015 & 2019
Figure 26. Crude Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Crude Heparin Revenue Share by Type (2015-2020)
Figure 28. Global Crude Heparin Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Crude Heparin Revenue Share by Application (2015-2020)
Figure 30. Global Crude Heparin Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Crude Heparin Sales Market Share by Type in 2019
Figure 32. United States Crude Heparin Sales Market Share by Type in 2019
Figure 33. Europe Crude Heparin Sales Market Share by Company in 2019
Figure 34. Europe Crude Heparin Sales Market Share by Type in 2019
Figure 35. Europe Crude Heparin Sales Market Share by Application in 2019
Figure 36. China Crude Heparin Sales Market Share by Company in 2019
Figure 37. China Crude Heparin Sales Market Share by Type in 2019
Figure 38. China Crude Heparin Sales Market Share by Application in 2019
Figure 39. Japan Crude Heparin Sales Market Share by Company in 2019
Figure 40. Japan Crude Heparin Sales Market Share by Type in 2019
Figure 41. Japan Crude Heparin Sales Market Share by Application in 2019
Figure 42. Southeast Asia Crude Heparin Sales Market Share by Company in 2019
Figure 43. Southeast Asia Crude Heparin Sales Market Share by Type in 2019
Figure 44. Southeast Asia Crude Heparin Sales Market Share by Application in 2019
Figure 45. India Crude Heparin Sales Market Share by Company in 2019
Figure 46. India Crude Heparin Sales Market Share by Type in 2019
Figure 47. India Crude Heparin Sales Market Share by Application in 2019
Figure 48. Shenzhen Hepalink Pharmaceutical Group Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Bioiberica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Fengrun Biological Technology Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Nanjing King-friend Biochemical Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Hebei Changshan Biochemical Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Changzhou Qianhong Biopharma Co.,Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Aspen Oss Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Hepac (Darling Ingredients) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Yantai Dongcheng Biochemicals Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Huaian MDC Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Crude Heparin
Figure 61. Manufacturing Process Analysis of Crude Heparin
Figure 62. Crude Heparin Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
ヘパリンカルシウムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Heparin Calcium market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Heparin Calcium market report…- ヘパリンコーティングステントの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Heparin Coated Stent market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Heparin Coated Stent mar…
- プレフィルドヘパリンロックシリンジの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pre-Filled Heparin Lock Syringe market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pre-Filled He…
- ヘパリンナトリウム注射の世界市場レポート2020 A recently published report by QY Research titled Global Heparin Sodium Injection Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides ac…
- ペプチド及びヘパリンの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Peptide and Heparin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Peptide and Heparin marke…